Express Pharma - Page 169 of 2207 - Express Pharma

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra

USV launches Xenia: Empagliflozin and its combinations for diabetes care in India

Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension

Ahmedabad Pharma Summit | 16th April 2025

Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset

Lupin gains tentative USFDA approval for Amifampridine Tablets

Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition

Zydus receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg